2019 Chicago International Breast Course: Advancing the Art of Breast Imaging
SESSION I • BREAST CANCER SCREENING
• Why are Screening Mammography Guidelines Controversial?
• Can Population-based and Personalized Screening Coexist?
• Abbreviated MRI for Screening
• Supplemental Screening Modalities: What Kinds of Cancers Do We Find?
SESSION II • BREAST DENSITY AND BREAST CANCER RISK
• Breast Cancer Genetic Screening
• Tools for Quantitating Breast Density and Assessing Breast Cancer Risk
• Physiologic Influences on Breast Cancer Risk
• Molecular Breast Imaging: A Functional Breast Imaging Modality
SESSION III • MODALITY FOCUS: Digital Breast Tomosynthesis (DBT)
• DBT: A Better Mammogram for Screening?
• DBT for Diagnosis
• Implementing DBT in Your Practice
• Cancers Missed on Mammography and How to Avoid Them
• BI-RADS® for DBT
SESSION IV • ARTIFICIAL INTELLIGENCE
• KEYNOTE ADDRESS: Demystifying Artificial Intelligence in Women's Imaging
• CAD, Radiomics, and AI in Breast Imaging
• Integrating AI and Machine Learning into Breast Imaging: IT and Workflow Challenges
SESSION V • MODALITY FOCUS: Ultrasound
• Feature Analysis: BI-RADS® for Ultrasound
• Current Strategies for Reducing False Positives in US
• Future Strategies for Reducing False Positives: Optoacoustics and Contrast
• Breast Ultrasound at its Best
• US Screening in the USA: Technologist-performed HHUS
SESSION VI • MODALITY FOCUS: Automated Breast Ultrasound
• Countering Breast Density’s Limitations: AUS is Best
• Approaches to Automated US Interpretation: The Coronal View
• Management of Artifacts in Automated Breast Ultrasound
• Implementation of Automated US and Clinical Results
SESSION VII • MODALITY FOCUS: Breast MRI
• Indications for Breast MRI in 2019
• Gadolinium Toxicity and Non-contrast MRI
• Background Parenchymal Enhancement (BPE): A Clue to Increased Breast Cancer Risk
SESSION VIII • IMAGING-GUIDED INTERVENTIONS
• Emergent and Urgent Breast Ultrasound
• Imaging-Guided Intervention: Focus on Architectural Distortion
• DBT-guided Biopsy
• Managing High-risk Lesions: A Pathologists’ Perspective
SESSION IX • ECONOMICS AND QUALITY
• Quality Management and EQUIP
• The ACR Breast Commission’s Accomplishments and Future Goals
SESSION X • PREVENTION, TREATMENT, AND MANAGEMENT OF BREAST CANCER
• Surgical Management of Breast Cancer
• The Postsurgical Breast
• Management of the Axilla for Newly Diagnosed Breast Cancer Patients
• AJCC Tumor Staging
• Is Less Becoming More in Radiation Therapy?
Upon completion of this activity, participants will be able to:
- Define screening controversies and address the current state of breast cancer screening;
- Describe multimodality approaches to breast cancer screening and early diagnosis;
- Review the current American College of Radiology’s breast imaging practice parameters;
- Gain confidence and competence in supplemental ultrasound screening using hand held and automated devices;
- Apply risk strategies to management, treatment, and prevention of breast cancer;
- Define principles of artificial intelligence (AI) and applications to breast imaging practices;
- Develop personalized and coordinated breast care to optimize patient outcomes.
Northwestern Feinberg School of Medicine
NorthShore University HealthSystem
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine, the International Center for Postgraduate Medical Education (ICPME), and NorthShore University HealthSystem. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials.
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 19.5 hours of ARRT Category A continuing education credit.